- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Forkhead Box Proteins in Acute Myeloid Leukemia
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 6, Pages 865
Publisher
MDPI AG
Online
2019-06-21
DOI
10.3390/cancers11060865
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia
- (2019) V. Alfonso et al. LEUKEMIA
- Targeting FLT3 mutations in AML: review of current knowledge and evidence
- (2019) Naval Daver et al. LEUKEMIA
- Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors
- (2019) Mei Han et al. Frontiers in Oncology
- Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer
- (2019) Carter Barger et al. Cancers
- New Treatment Options for Acute Myeloid Leukemia in 2019
- (2019) Marco Cerrano et al. Current Oncology Reports
- Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
- (2019) Rory M. Shallis et al. BLOOD REVIEWS
- Correlation of TET2 SNP rs2454206 with improved survival in children with acute myeloid leukemia featuring intermediate-risk cytogenetics
- (2018) Xingjuan Wang et al. GENES CHROMOSOMES & CANCER
- Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia
- (2018) Andi Wang et al. Hematology
- FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer
- (2018) Abdul Rehman et al. JOURNAL OF CLINICAL PATHOLOGY
- Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
- (2018) Courtney D DiNardo et al. LANCET ONCOLOGY
- mTORC1 Promotes Metabolic Reprogramming by the Suppression of GSK3-Dependent Foxk1 Phosphorylation
- (2018) Long He et al. MOLECULAR CELL
- Members of FOX family could be drug targets of cancers
- (2018) Jinhua Wang et al. PHARMACOLOGY & THERAPEUTICS
- Mechanisms controlling the anti-neoplastic functions of FoxO proteins
- (2018) Tianyun Hou et al. SEMINARS IN CANCER BIOLOGY
- FoxM1 repression during human aging leads to mitotic decline and aneuploidy-driven full senescence
- (2018) Joana Catarina Macedo et al. Nature Communications
- Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation
- (2018) Minjeong Nam et al. Annals of Laboratory Medicine
- Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2
- (2018) Amir T. Fathi et al. JAMA Oncology
- Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations
- (2018) Michael Buege et al. Cancers
- Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells
- (2018) Lin Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- FLT3 inhibitors in acute myeloid leukemia
- (2018) Mei Wu et al. Journal of Hematology & Oncology
- Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
- (2018) Giulia Falconi et al. LEUKEMIA
- Functional genomic landscape of acute myeloid leukaemia
- (2018) Jeffrey W. Tyner et al. NATURE
- Subtype-specific regulatory network rewiring in acute myeloid leukemia
- (2018) Salam A. Assi et al. NATURE GENETICS
- Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy
- (2018) Samah Nassereddine et al. OncoTargets and Therapy
- Therapeutic targeting of isocitrate dehydrogenase mutant AML
- (2017) Prajwal Boddu et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- FOXO Signaling Pathways as Therapeutic Targets in Cancer
- (2017) Mohd Farhan et al. International Journal of Biological Sciences
- Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells
- (2017) Yuan-Feng Gao et al. ONCOLOGY REPORTS
- FOXQ1 regulates senescence-associated inflammation via activation of SIRT1 expression
- (2017) Pan Wang et al. Cell Death & Disease
- The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia
- (2017) Emiliano Fabiani et al. Oncotarget
- SUMOylation of FOXP1 regulates transcriptional repression via CtBP1 to drive dendritic morphogenesis
- (2017) Daniel L. Rocca et al. Scientific Reports
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Fox transcription factors: from development to disease
- (2016) Maria L. Golson et al. DEVELOPMENT
- Effect of FOXP3 polymorphism on the clinical outcomes after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia patients
- (2016) Zhe Piao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Nuclear FOXM1 drives chemoresistance in AML
- (2016) I Khan et al. LEUKEMIA
- Isocitrate dehydrogenase mutations in myeloid malignancies
- (2016) B C Medeiros et al. LEUKEMIA
- Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
- (2016) Andrew P. Feinberg et al. NATURE REVIEWS GENETICS
- Mutations in epigenetic modifiers in acute myeloid leukemia and their clinical utility
- (2016) Hsin-An Hou et al. Expert Review of Hematology
- Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
- (2016) M. Konopleva et al. Cancer Discovery
- FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells
- (2016) Uday B. Maachani et al. Oncotarget
- Current Management of Childhood Acute Myeloid Leukemia
- (2016) Jeffrey E. Rubnitz PEDIATRIC DRUGS
- Mechanisms of mesenchymal stem/stromal cell function
- (2016) Jeffrey L. Spees et al. Stem Cell Research & Therapy
- Frequent Derepression of the Mesenchymal Transcription Factor Gene FOXC1 in Acute Myeloid Leukemia
- (2015) Tim D.D. Somerville et al. CANCER CELL
- FOXOs support the metabolic requirements of normal and tumor cells by promoting IDH1 expression
- (2015) P. Charitou et al. EMBO REPORTS
- A Novel Function of Molecular Chaperone HSP70
- (2015) Marianna Halasi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
- (2015) C. Michel Zwaan et al. JOURNAL OF CLINICAL ONCOLOGY
- Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children’s Oncology Group
- (2015) M A Kutny et al. LEUKEMIA
- Isocitrate dehydrogenase mutations in gliomas
- (2015) Matthew S. Waitkus et al. NEURO-ONCOLOGY
- Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature
- (2015) Pierre Cauchy et al. Cell Reports
- Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia
- (2014) Long-long Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- FOXP1inhibits cell growth and attenuates tumorigenicity of neuroblastoma
- (2014) Sandra Ackermann et al. BMC CANCER
- Bone marrow stromal cells in the pathogenesis of acute myeloid leukemia
- (2014) Olga Blau Frontiers in Bioscience-Landmark
- Targeting forkhead box transcription factors FOXM1 and FOXO in leukemia (Review)
- (2014) HONG ZHU ONCOLOGY REPORTS
- TheBCL2L10Leu21Arg variant and risk of therapy-related myeloid neoplasms andde novomyelodysplastic syndromes
- (2013) Emiliano Fabiani et al. LEUKEMIA & LYMPHOMA
- Distinct poor prognostic subgroups of acute myeloid leukaemia, FLT3-ITD and P-glycoprotein-positive, have contrasting levels of FOXO1
- (2013) Claire H. Seedhouse et al. LEUKEMIA RESEARCH
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel functions of FoxM1: from molecular mechanisms to cancer therapy
- (2013) Mónica Alvarez-Fernández et al. Frontiers in Oncology
- The DNA demethylating agent decitabine activates the TRAIL pathway and induces apoptosis in acute myeloid leukemia
- (2012) Matías Soncini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- FOXO1 is a tumor suppressor in classical Hodgkin lymphoma
- (2012) L. Xie et al. BLOOD
- Bortezomib Added to Daunorubicin and Cytarabine During Induction Therapy and to Intermediate-Dose Cytarabine for Consolidation in Patients With Previously Untreated Acute Myeloid Leukemia Age 60 to 75 Years: CALGB (Alliance) Study 10502
- (2012) Eyal C. Attar et al. JOURNAL OF CLINICAL ONCOLOGY
- The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia
- (2012) Xiaolu Zhang et al. Molecular Cancer
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival
- (2011) Antònia Obrador-Hevia et al. BRITISH JOURNAL OF HAEMATOLOGY
- AKT/FOXO Signaling Enforces Reversible Differentiation Blockade in Myeloid Leukemias
- (2011) Stephen M. Sykes et al. CELL
- Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia
- (2011) Sylvain Thépot et al. CELL CYCLE
- Nucleophosmin Interacts with FOXM1 and Modulates the Level and Localization of FOXM1 in Human Cancer Cells
- (2011) Uppoor G. Bhat et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic Advances in Acute Myeloid Leukemia
- (2011) Alan Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolism unhinged: IDH mutations in cancer
- (2011) John R Prensner et al. NATURE MEDICINE
- FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
- (2011) C T Karadedou et al. ONCOGENE
- FOXO3A as a key molecule for all-trans retinoic acid-induced granulocytic differentiation and apoptosis in acute promyelocytic leukemia
- (2010) Y. Sakoe et al. BLOOD
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia
- (2010) S. Nakamura et al. CARCINOGENESIS
- Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
- (2010) N. Chapuis et al. CLINICAL CANCER RESEARCH
- Highly Phosphorylated FOXO3A Is an Adverse Prognostic Factor in Acute Myeloid Leukemia
- (2010) S. M. Kornblau et al. CLINICAL CANCER RESEARCH
- IDH1andIDH2Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2010) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
- (2010) Peter Paschka et al. JOURNAL OF CLINICAL ONCOLOGY
- TGF-β–FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
- (2010) Kazuhito Naka et al. NATURE
- Cancer-associated IDH mutations: biomarker and therapeutic opportunities
- (2010) K E Yen et al. ONCOGENE
- High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics
- (2009) Carlos M. Santamaría et al. LEUKEMIA RESEARCH
- The evolution of Fox genes and their role in development and disease
- (2009) Sridhar Hannenhalli et al. NATURE REVIEWS GENETICS
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- FoxM1 Is a General Target for Proteasome Inhibitors
- (2009) Uppoor G. Bhat et al. PLoS One
- Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells
- (2008) C.-Y. Han et al. CARCINOGENESIS
- Sustained NF-κB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1
- (2008) Marianna Penzo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia
- (2008) M T Voso et al. LEUKEMIA
- Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells
- (2008) R. C-Y. Hui et al. MOLECULAR CANCER THERAPEUTICS
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
- (2008) Jer-Yen Yang et al. NATURE CELL BIOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- Complementing mutations in core binding factor leukemias: from mouse models to clinical applications
- (2008) A M S Müller et al. ONCOGENE
- The FoxO code
- (2008) D R Calnan et al. ONCOGENE
- FoxO tumor suppressors and BCR–ABL-induced leukemia: A matter of evasion of apoptosis
- (2007) Zainab Jagani et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started